Spanish public university with broad biomedical, digital society, and humanities research capacity, active Marie Curie fellowship host across 44 partner countries.
The University of Salamanca is one of Spain's oldest universities, operating as a broad-spectrum research institution with particular depth in biomedical sciences, fundamental physics, and digital society research. They conduct clinical and translational research in areas ranging from neurodevelopmental disorders (autism, intellectual disability) to cancer diagnostics and vaccine development. The university also maintains strong capacity in Marie Skłodowska-Curie individual fellowships, hosting international researchers across disciplines from nanoplankton ecology to medieval palaeography, and has organized flagship EU science events including the European Union Contest for Young Scientists.
Projects spanning vaccines (PERISCOPE), cancer screening (TiMaScan), Batten disease therapy (BATCure), autism biomarkers (AIMS-2-TRIALS), drug safety (TransBioLine), and glioblastoma metabolism (MITIG).
Ten MSCA-IF fellowships across diverse topics — from strong-field physics (HHGhole2) to bacterial cellulases (BIOFERTICELLULASER) to CO2 nanoplankton response (SONAR-CO2) — showing capacity to host and supervise international early-career researchers.
Projects on demand response for smart grids (DREAM-GO), electricity market negotiation (ADAPT), and electric field control of magnetism for energy-efficient electronics (MagnEFi).
Projects on digital empowerment of youth (WYRED), serious games for confidence building (e-Confidence), distributed ledger ethical frameworks (AnticipatoryLedgers), and startup ecosystem development (SEP 2.0, MY-GATEWAY).
Recent ERC-funded medieval palaeography project (PeopleAndWriting) and underwater cultural heritage preservation (TECTONIC), both running 2020-2025.
Southern Ocean nanoplankton and CO2 (SONAR-CO2), Mediterranean salinity crisis geology (SALTGIANT), and subsurface remediation with metal oxides (METAL-AID).
In the early H2020 period (2014–2018), Salamanca focused heavily on social sciences (job quality, inequality, employment), vaccine and biomarker discovery (pertussis, cancer screening via flow cytometry), and smart grid technologies. From 2019 onward, their portfolio shifted toward neurodevelopmental disorders (autism biomarkers, intellectual disability), drug safety qualification, fundamental physics (quantum chromodynamics, hadron structure), and humanities research including medieval written culture. The university has broadened from applied digital and social research toward more fundamental science and translational medicine.
Salamanca is moving toward deeper translational biomedical research and fundamental science (physics, humanities), suggesting future partners should look here for clinical biomarker expertise and interdisciplinary research hosting rather than applied technology development.
Salamanca balances coordination (15 of 41 projects) with partnership roles (25 projects), showing comfort both leading smaller projects and contributing specialist expertise to large consortia. Their 564 unique partners across 44 countries indicate a highly networked institution that builds wide rather than deep relationships — a hub connector rather than a loyal-cluster collaborator. This makes them easy to approach for new consortia, as they are experienced in onboarding new partners and managing diverse teams.
With 564 unique consortium partners spanning 44 countries, Salamanca operates one of the broader collaboration networks among Spanish universities in H2020. Their reach extends well beyond the Iberian Peninsula into Northern and Eastern Europe, with no obvious geographic concentration.
Salamanca's distinctiveness lies in its unusual combination of deep biomedical expertise with strong humanities and social science capacity — a combination rare among technically oriented H2020 participants. Their high MSCA fellowship count (10 projects) signals an excellent research environment for hosting visiting scientists, making them particularly attractive for mobility-focused proposals. As one of Europe's oldest universities (founded 1218), they bring institutional credibility and administrative maturity that reduces consortium risk.
